How genetics, lifestyle promote cognitive health in older adults
For the first time, University of Hawaiʻi at Mānoa researchers have studied how work, volunteering and leisure activities ...
Maze Therapeutics doses first subject in Phase II AKD treatment trial
Maze Therapeutics has dosed the first subject in the Phase II HORIZON study to evaluate its oral apolipoprotein L1 (APOL1) ...